GIOMMONI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 718
NA - Nord America 439
AS - Asia 173
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.333
Nazione #
US - Stati Uniti d'America 437
PL - Polonia 302
IT - Italia 161
IE - Irlanda 107
HK - Hong Kong 68
SE - Svezia 57
AT - Austria 36
CN - Cina 30
JO - Giordania 30
IN - India 18
CH - Svizzera 16
SG - Singapore 13
VN - Vietnam 12
DE - Germania 8
RU - Federazione Russa 8
GB - Regno Unito 7
FI - Finlandia 5
UA - Ucraina 3
CA - Canada 2
ES - Italia 2
FR - Francia 2
NL - Olanda 2
TR - Turchia 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
EG - Egitto 1
Totale 1.333
Città #
Warsaw 302
Dublin 101
Fairfield 54
Chandler 53
Hong Kong 52
Ashburn 40
Vienna 36
Seattle 29
Florence 25
Houston 24
Cambridge 20
Pune 18
Wilmington 18
Bern 16
Lawrence 16
Woodbridge 16
Altamura 15
Milan 14
Dong Ket 12
Princeton 12
Shanghai 12
Beijing 10
Buffalo 10
Moscow 8
Boston 7
Singapore 7
Ann Arbor 6
Bremen 6
Brescia 6
Dearborn 6
New York 6
Rome 6
San Diego 6
Medford 5
Amandola 4
Falls Church 4
Hillsboro 4
Naples 4
Alba 3
Boardman 3
Hangzhou 3
Helsinki 3
Mykolayiv 3
Washington 3
Ancona 2
Argelato 2
Barcelona 2
Brusaporto 2
Carmignano 2
Cinisello Balsamo 2
Istanbul 2
Jinan 2
London 2
Orta Nova 2
Padova 2
Palermo 2
Paris 2
Parma 2
Perugia 2
Phoenix 2
Pietrasanta 2
Reggio Emilia 2
San Giovanni Valdarno 2
Shenzhen 2
Toronto 2
Varese 2
Vico Equense 2
Andover 1
Augusta 1
Banbridge 1
Brussels 1
Cagliari 1
Chicago 1
Düsseldorf 1
Fontebuona 1
Garden City 1
Genoa 1
Jacksonville 1
Kunming 1
La Spezia 1
Laurel 1
Lyngby 1
Modena 1
Nettuno 1
Pescara 1
Petriolo 1
Prescot 1
San Piero in Bagno 1
San Severo 1
Sasso Marconi 1
Sesto Fiorentino 1
Siena 1
Southwark 1
St Albans 1
Subbiano 1
Sydney 1
Teramo 1
Torri di Quartesolo 1
Trento 1
Trumbull 1
Totale 1.087
Nome #
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 226
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 162
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 110
Update on gastric cancer treatments and gene therapies 93
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 85
Regorafenib also can cause osteonecrosis of the jaw 80
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 61
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 57
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 51
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 41
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 40
Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers 40
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) 34
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 31
Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations 29
Results of the observational prospective RealFLOT study 28
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 28
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 26
Somatostatin analogs in pregnant patients with neuroendocrine tumor 26
Systemic Sclerosis Association with Malignancy 23
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research 21
Response 20
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine 15
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 14
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 13
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 9
Immune-related adverse events in oncological patients treated with immune checkpoint inhibitors 7
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 4
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 3
null 3
Totale 1.380
Categoria #
all - tutte 6.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 8 15 13
2019/2020171 9 10 6 12 20 22 17 21 14 11 25 4
2020/2021209 17 21 0 31 14 20 14 13 24 35 6 14
2021/202288 2 2 3 2 4 0 4 15 4 8 20 24
2022/2023435 17 53 16 23 32 90 58 39 53 13 19 22
2023/2024337 8 27 30 24 29 71 27 82 11 28 0 0
Totale 1.380